newsgirl
April 2nd, 2009, 03:23 PM
<img alt="" height="1" width="1">
Pfizer Halts One Study of Sutent for Breast Cancer (http://news.google.com/news/url?sa=T&ct=us/0-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601103%26sid%3DaXHuEeih2fBw%26refer %3Dus&cid=1324823616&ei=KsrUSbutC5yHmQfiooniCA&usg=AFQjCNFVUfDC3n5Ftj3NE65MhJEsJpN9Tg)
Bloomberg
Pfizer rose 37 cents, or 2.7 percent, to $13.99 at the closed of New York Stock Exchange composite trading yesterday. The company has dropped 35 percent in the past 12 months. Pfizer and drugmaker Bristol-Myers Squibb Co. have been racing the develop ...
Link to News Article... (http://news.google.com/news/url?sa=T&ct=us/0-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601103%26sid%3DaXHuEeih2fBw%26refer %3Dus&cid=1324823616&ei=KsrUSbutC5yHmQfiooniCA&usg=AFQjCNFVUfDC3n5Ftj3NE65MhJEsJpN9Tg)
Pfizer Halts One Study of Sutent for Breast Cancer (http://news.google.com/news/url?sa=T&ct=us/0-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601103%26sid%3DaXHuEeih2fBw%26refer %3Dus&cid=1324823616&ei=KsrUSbutC5yHmQfiooniCA&usg=AFQjCNFVUfDC3n5Ftj3NE65MhJEsJpN9Tg)
Bloomberg
Pfizer rose 37 cents, or 2.7 percent, to $13.99 at the closed of New York Stock Exchange composite trading yesterday. The company has dropped 35 percent in the past 12 months. Pfizer and drugmaker Bristol-Myers Squibb Co. have been racing the develop ...
Link to News Article... (http://news.google.com/news/url?sa=T&ct=us/0-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601103%26sid%3DaXHuEeih2fBw%26refer %3Dus&cid=1324823616&ei=KsrUSbutC5yHmQfiooniCA&usg=AFQjCNFVUfDC3n5Ftj3NE65MhJEsJpN9Tg)